Systematic review: Antimicrobial urinary catheters to prevent catheter-associated urinary tract infection in hospitalized patients

Annals of Internal Medicine

Volumn 144, Issue 2, 2006, Pages 116-126

  Johnson, James R ^a,b   Kuskowski, Michael A ^a,b   Wilt, Timothy J ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; NITROFURAL; SILVER; URINARY TRACT ANTIINFECTIVE AGENT;

BACTERIURIA; BURNING SENSATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DEVICE INFECTION; DRUG FATALITY; HEALTH CARE COST; HEMATURIA; HOSPITAL PATIENT; HUMAN; MORTALITY; PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SEPSIS; SYSTEMATIC REVIEW; URETHRA DISEASE; URINARY TRACT INFECTION; URINE CATHETER; CATHETERIZATION; EQUIPMENT DESIGN; FEMALE; HOSPITALIZATION; INSTRUMENTATION; MALE;

ANTI-INFECTIVE AGENTS, URINARY; BACTERIURIA; EQUIPMENT DESIGN; FEMALE; HOSPITALIZATION; HUMANS; MALE; NITROFURAZONE; RANDOMIZED CONTROLLED TRIALS; SILVER; URINARY CATHETERIZATION; URINARY TRACT INFECTIONS;

EID: 33644809111     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-144-2-200601170-00009     Document Type: Review

References (44)

1. Saint S, Chenoweth CE. Biofilms and catheter-associated urinary tract infections. Infect Dis Clin North Am. 2003;17:411-32.
2. Warren JW. The catheter and urinary tract infection. Med Clin North Am. 1991;75:481-93.
3. Maki DG, Tambyah PA. Engineering out the risk for infection with urinary catheters. Emerg Infect Dis. 2001;7:342-7.
4. Saint S, Lipsky BA, Goold SD. Indwelling urinary catheters: a one-point restraint? [Editorial]. Ann Intern Med. 2002;137:125-7.
5. Tambyah PA, Maki DG. Catheter-associated urinary tract infection is rarely symptomatic: a prospective study of 1,497 catheterized patients. Arch Intern Med. 2000;160:678-82.
6. Bryan CS, Reynolds KL. Hospital-acquired bacteremic urinary tract infection: epidemiology and outcome. J Urol. 1984;132:494-8.
7. Krieger JN, Kaiser DL, Wenzel RP. Urinary tract etiology of bloodstream infections in hospitalized patients. J Infect Dis. 1983;148:57-62.
8. Eykyn SJ. Urinary tract infections in the elderly. Br J Urol. 1998;82 Suppl 1:79-84.
9. Platt R, Polk BF, Murdock B, Rosner B. Mortality associated with nosocomial urinary-tract infection. N Engl J Med. 1982;307:637-42.
10. Gross PA, Van Antwerpen C. Nosocomial infections and hospital deaths. A case-control study. Am J Med. 1983;75:658-62.
11. Bueno-Cavanillas A, Delgado-Rodríguez M, López-Luque A, Schaffino-Cano S, Gálvez-Vargas R. Influence of nosocomial infection on mortality rate in an intensive care unit. Crit Care Med. 1994;22:55-60.
12. Laupland KB, Bagshaw SM, Gregson DB, Kirkpatrick AW, Ross T, Church DL. Intensive care unit-acquired urinary tract infections in a regional critical care system. Crit Care. 2005;9:R60-5.
13. Tambyah PA, Knasinski V, Maki DG. The direct costs of nosocomial catheter-associated urinary tract infection in the era of managed care. Infect Control Hosp Epidemiol. 2002;23:27-31.
14. Karchmer TB, Giannetta ET, Muto CA, Strain BA, Farr BM. A randomized crossover study of silver-coated urinary catheters in hospitalized patients. Arch Intern Med. 2000;160:3294-8.
15. Cornia PB, Amory JK, Fraser S, Saint S, Lipsky BA. Computer-based order entry decreases duration of indwelling urinary catheterization in hospitalized patients. Am J Med. 2003;114:404-7.
16. Trinkaus D. Reductions of ICU nosocomial catheter-associated urinary tract infections [Abstract]. Am J Infect Control. 2004;32:E105.
17. Saint S, Lipsky BA. Preventing catheter-related bacteriuria: should we? Can we? How? Arch Intern Med. 1999;159:800-8.
18. Warren J, Bakke A, Desgranchamps F, Johnson JR, Kumon H, Shah J, Tambyah P. Catheter-associated bacteriuria and the role of biomaterial in prevention. In: Naber KG, Pechere JC, Kumazawa J, Khoury S, Gerberding JL, Schaeffer AJ, eds. Nosocomial and Health Care Associated Infections in Urology. Plymouth, United Kingdom: Health Publication Ltd.; 2001:151-76.
19. Saint S, Elmore JG, Sullivan SD, Emerson SS, Koepsell TD. The efficacy of silver alloy-coated urinary catheters in preventing urinary tract infection: a metaanalysis. Am J Med. 1998;105:236-41.
20. Brosnahan J, Jull A, Tracy C. Types of urethral catheters for management of short-term voiding problems in hospitalised adults. Cochrane Database Syst Rev. 2004:CD004013.
21. Hartling L, McAlister FA, Rowe BH, Ezekowitz J, Friesen C, Klassen TP. Challenges in systematic reviews of therapeutic devices and procedures. Ann Intern Med. 2005;142:1100-11.
22. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995;273:408-12.
23. Liedberg H, Lundeberg T, Ekman P. Refinements in the coating of urethral catheters reduces the incidence of catheter-associated bacteriuria. An experimental and clinical study. Eur Urol. 1990;17:236-40.
24. Liedberg H, Lundeberg T. Silver alloy coated catheters reduce catheter-associated bacteriuria. Br J Urol. 1990;65:379-81.
25. Verleyen P, De Ridder D, Van Poppel H, Baert L. Clinical application of the Bardex IC Foley catheter. Eur Urol. 1999;36:240-6.
26. Thibon P, Le Coutour X, Leroyer R, Fabry J. Randomized multi-centre trial of the effects of a catheter coated with hydrogel and silver salts on the incidence of hospital-acquired urinary tract infections. J Hosp Infect. 2000;45:117-24.
27. Al-Habdan I, Sadat-Ali M, Corea JR, Al-Othman A, Kamal BA, Shriyan DS. Assessment of nosocomial urinary tract infections in orthopaedic patients: a prospective and comparative study using two different catheters. Int Surg. 2003; 88:152-4.
28. Lundeberg T. Prevention of catheter-associated urinary-tract infections by use of silver-impregnated catheters [Letter]. Lancet. 1986;2:1031.
29. Liedberg H, Lundeberg T. Prospective study of incidence of urinary tract infection in patients catheterized with Bard hydrogel and silver-coated catheters or Bard hydrogel-coated catheters [Abstract]. J Urol. 1993;149:405A.
30. Maki DG, Knasinski V, Tambyah PA. A prospective investigator-blinded trial of a novel nitrofurazone-impregnated urinary catheter [Abstract]. Infect Control Hosp Epidemiol. 1997;18:P50.
31. Maki DG, Knasinski V, Halvorson KT, Tambyah PA. A novel silverhydrogel urinary catheter reduces catheter-associated urinary tract infections. A prospective, randomized, double-blind trial [Abstract]. Infect Control Hosp Epidemiol. 1998;19:682.
32. Lee SJ, Kim SW, Cho YH, Shin WS, Lee SE, Kim CS, et al. A comparative multicentre study on the incidence of catheter-associated urinary tract infection between nitrofurazone-coated and silicone catheters. Int J Antimicrob Agents. 2004;24 Suppl 1:S65-9.
33. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988;16:128-40.
34. Johnson JR, Berggren T, Conway AJ. Activity of a nitrofurazone matrix urinary catheter against catheter-associated uropathogens. Antimicrob Agents Chemother. 1993;37:2033-6.
35. Saint S, Veenstra DL, Sullivan SD, Chenoweth C, Fendrick AM. The potential clinical and economic benefits of silver alloy urinary catheters in preventing urinary tract infection. Arch Intern Med. 2000;160:2670-5.
36. Turjanmaa K, Alenius H, Reunala T, Palosuo T. Recent developments in latex allergy. Curr Opin Allergy Clin Immunol. 2002;2:407-12.
37. Hepner DL, Castells MC. Latex allergy: an update. Anesth Analg. 2003;96:1219-29.
38. Taylor JS, Erkek E. Latex allergy: diagnosis and management. Dermatol Ther. 2004;17:289-301.
39. Srinivasan A, Karchmer T, Richards A, Sng X, Perl TM. A prospective trial of a novel, silicone based, silver coated foley catheter for the prevention of nosocomial urinary tract infections. Infect Control Hosp Epidemiol. 2005 [In press].
40. Rupp ME, Fitzgerald T, Marion N, Helget V, Puumala S, Anderson JR, et al. Effect of silver-coated urinary catheters: efficacy, cost-effectiveness, and antimicrobial resistance. Am J Infect Control. 2004;32:445-50.
41. Burt B, Pace D, Calabrese C. Reduction of healthcare-acquired urinary tract infections - a patient safety analysis [Abstract]. Am J Infect Control. 2004;32:E78.
42. Lai KK, Fontecchio SA. Use of silver-hydrogel urinary catheters on the incidence of catheter-associated urinary tract infections in hospitalized patients. Am J Infect Control. 2002;30:221-5.
43. Newton T, Still JM, Law E. A comparison of the effect of early insertion of standard latex and silver-impregnated latex foley catheters on urinary tract infections in burn patients. Infect Control Hosp Epidemiol. 2002;23:217-8.
44. Plowman R, Graves N, Esquivel J, Roberts JA. An economic model to assess the cost and benefits of the routine use of silver alloy coated urinary catheters to reduce the risk of urinary tract infections in catheterized patients. J Hosp Infect. 2001;48:33-42.